Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Lieke A S van KerkhovenJan B M J Jansen

Abstract

Antidepressants could be effective in the treatment of functional gastrointestinal disorders through their anticholinergic and pain-modulating effects. Previous studies with these drugs lacked sufficient power and were predominantly conducted in patients with irritable bowel syndrome. This study aimed to assess the effectiveness of the serotonin and norepinephrine reuptake inhibitor venlafaxine in patients with functional dyspepsia. This was a multi-center, randomized, double-blind, placebo-controlled trial. Participants had persistent dyspeptic symptoms and underwent upper gastrointestinal endoscopy in a secondary care hospital to exclude organic abnormalities. They were randomly assigned to receive 8 weeks of treatment with either venlafaxine XR (2 weeks 75 mg once daily, 4 weeks 150 mg once daily, and 2 weeks 75 mg once daily) or placebo. Symptoms, health-related quality of life, anxiety, and depression were assessed before and at 4, 8, 12, and 20 weeks after inclusion. One hundred sixty patients were randomized; 56% and 73% of participants completed treatment with venlafaxine or placebo, respectively, according to protocol. There was no difference in proportions of symptom-free patients after 8 weeks of treatment or at 20 w...Continue Reading

Citations

Dec 19, 2008·Nature Clinical Practice. Gastroenterology & Hepatology·Lukas Van Oudenhove, Jan Tack
Oct 14, 2009·Journal of Gastroenterology and Hepatology·Nicholas J Talley, Rok Seon Choung
Dec 7, 2011·Journal of Gastroenterology and Hepatology·Hiroto MiwaYoung-Tae Bak
Dec 23, 2009·World Journal of Gastroenterology : WJG·Klaus BielefeldtSusan L Zickmund
Nov 17, 2012·World Journal of Gastroenterology : WJG·Victoria P Y TanBenjamin C Y Wong
Jun 11, 2010·Journal of Neurogastroenterology and Motility·Jong Chan Lee, Su Jin Hong
Feb 11, 2012·Journal of Neurogastroenterology and Motility·Justin Cy Wu
Apr 24, 2012·Journal of Neurogastroenterology and Motility·Hiroto MiwaYoung-Tae Bak
Jan 1, 2012·Scientifica·Klaus Bielefeldt
Dec 10, 2013·Gastroenterología y hepatología·Juan J Sebastián-Domingo
Aug 30, 2014·Current Treatment Options in Gastroenterology·Benjamin SteinBrian E Lacy
Jun 20, 2013·Expert Opinion on Pharmacotherapy·Baharak MoshireeNicholas Talley
Mar 19, 2011·Expert Opinion on Emerging Drugs·Jan Tack, Pieter Janssen
Jan 16, 2013·Expert Opinion on Investigational Drugs·Roy DekelAmi D Sperber
Apr 25, 2014·The Medical Clinics of North America·Maryann Katherine Overland
Feb 24, 2016·Women's Health·Kate NapthaliNicholas J Talley
May 7, 2013·Asian Journal of Psychiatry·Mahbobeh FaramarziJavad Shokri-shirvani
Nov 29, 2012·Gastroenterología y hepatología·Javier P GisbertUNKNOWN Sociedad Española de Medicina de Familia y Comunitaria
Feb 22, 2011·Gastroenterology Clinics of North America·Madhusudan Grover, Douglas A Drossman
Oct 19, 2010·Gastroenterology Clinics of North America·Michael Camilleri, Jan F Tack
Aug 12, 2009·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·L Van Oudenhove, Q Aziz
Feb 24, 2009·Gastrointestinal Endoscopy Clinics of North America·Madhusudan Grover, Douglas A Drossman
Jan 25, 2011·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·P JanssenJ Tack
Jul 20, 2013·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J SongJ D Z Chen
Feb 19, 2014·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M R OstovanehS A Mirbagheri
Feb 5, 2015·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·H Törnblom, D A Drossman
Apr 29, 2015·Journal of Gastroenterology·Nicholas J TalleyMarjorie M Walker
Oct 6, 2012·Atencion primaria·Javier P GisbertUNKNOWN Centro Cochrane Iberoamericano
Nov 5, 2015·The New England Journal of Medicine·Nicholas J Talley, Alexander C Ford
Apr 7, 2016·The Korean Journal of Internal Medicine·Nicholas J Talley
Mar 30, 2017·The American Journal of Gastroenterology·W Harley SobinDouglas A Drossman
Apr 18, 2017·Revista de gastroenterología de México·R Carmona-SánchezJ A Velarde-Ruiz Velasco
Dec 25, 2010·Therapeutic Advances in Gastroenterology·Rita Brun, Braden Kuo
May 12, 2016·Inflammatory Bowel Diseases·Gregory ThorkelsonEva Szigethy
Jul 8, 2010·The American Journal of Gastroenterology·Radu Tutuian
Dec 7, 2010·The American Journal of Gastroenterology·Brian E LacyMichael Camilleri
Jan 9, 2013·Nature Reviews. Gastroenterology & Hepatology·Eamonn M M Quigley, Brian E Lacy
Feb 6, 2013·Nature Reviews. Gastroenterology & Hepatology·Michael Camilleri, Vincenzo Stanghellini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.